Invech Holdings, Inc.
IVHI
$0.0176
$0.002617.33%
| Weiss Ratings | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 17.33% | |||
| 60-Day Total Return | 17.33% | |||
| 90-Day Total Return | 17.33% | |||
| Year to Date Total Return | 17.33% | |||
| 1-Year Total Return | 486.67% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 214.29% | |||
| Price | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.02 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Jun 20, 2024 | |||
| 52-Week High Price (Date) | Feb 24, 2025 | |||
| Valuation | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.77M | |||
| Enterprise Value | 1.77M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -21.88% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -176.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -4.36 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 49.97M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 602 793 8058 | |||
| Address | 7339 East Williams Drive Scottsdale, AZ 85255 | |||
| Website | invechconsulting.com | |||
| Country | United States | |||
| Year Founded | 1998 | |||
| Profitability | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -911.14% | |||
| Return on Equity | -- | |||
| Income Statement | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -60.50K | |||
| Net Income (TTM) | -60.50K | |||
| Net Income Avl. to Common (TTM) | -60.50K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 74.15% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 93.94% | |||
| Balance Sheet | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | -- | |||
| Cash Per Share (Q) | -- | |||
| Total Current Assets (Q) | 1.30K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -8.60K | |||
| Current Ratio (Q) | 0.133 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 1.30K | |||
| Total Current Liabilities (Q) | 9.80K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 9.80K | |||
| Total Common Equity (Q) | -8.90K | |||
| Cash Flow | IVHI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 54.80K | |||
| Net Change in Cash (TTM) | -7.00K | |||
| Levered Free Cash Flow (TTM) | -3.80K | |||
| Cash from Operations (TTM) | -61.80K | |||
